Physician profile
Anna Beyer
NPI 1528196185
$11,274.85
in general payments reported to CMS, 2019-2025
26 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,239 · 2020: $72.57 · 2021: $1,154 · 2022: $687 · 2023: $392 · 2024: $1,230 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,400.61 | 2019-2021 | |
| Boston Scientific Corporation | $1,967.85 | 2019-2025 | General - Therapies, Avvigo Guidance System, Rotapro |
| Medtronic, INC. | $649.39 | 2022-2025 | Symplicity G3, Ffrangio |
| Abbott Laboratories | $567.16 | 2024-2025 | Dragonfly Opstar, Triclip, Coroflow |
| Shockwave Medical, INC | $514.17 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $510.56 | 2019-2020 | |
| Abiomed | $402.91 | 2021-2025 | |
| Cardiovascular Systems INC. | $157.32 | 2019-2020 | |
| Philips North America LLC | $156.57 | 2019-2025 | (9266) Elca, (6585) Omniwire, (Bq9) Coronary Ivus |
| Teleflex LLC | $130.50 | 2025 | Guideliner |
| Amgen INC. | $128.13 | 2019 | |
| Edwards Lifesciences Corporation | $102.28 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $81.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.07 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $66.72 | 2019 | |
| Cathworks, INC. | $50.14 | 2019-2020 | |
| Biosense Webster, INC. | $33.44 | 2019 | |
| Irhythm Technologies, INC. | $31.07 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.73 | 2022 | |
| Chiesi USA, INC. | $28.82 | 2019 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Astellas Pharma US INC | $22.39 | 2019 | |
| Pfizer INC. | $21.21 | 2019 | |
| Lundbeck LLC | $21.03 | 2019 | |
| Heartflow, INC. | $17.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Beyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.